SciClone Pharmaceuticals
SciClone profit up 4.3% to RMB622.7m in H1 2021
SciClone profit up 4.3% to RMB622.7m in H1 2021
Its revenue rose 14.7% to RMB1.3b in the same period.
Most Read
1. IHH Healthcare expands cancer treatment support in Malaysia 2. Japan delays medical expense reforms amidst political pushback 3. Philippines to cut power costs in healthcare facilities 4. Singapore adds special care dentistry as eighth dental speciality 5. Global venipuncture procedure market to hit $1.5b by 2030Resource Center
Read Here
Advertise
Sign Up
Event News
The medical institution earned recognition for its National Hospital Apps which have brought digital revolution in healthcare.
Commentary
Biomedical textiles: Novel fabrics supporting enhanced patient care in Asia-Pacific